ORNBV:OMXHEXOrion Oyj Class B Analysis
Data as of 2026-03-14 - not real-time
€68.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading above its immediate support level with the 20‑day SMA sitting just above the 50‑day SMA, confirming a bullish bias. Momentum indicators are mixed – RSI sits near the neutral zone and the MACD histogram has turned negative, while the overall trend remains bullish. Volatility is elevated, exceeding 40% on a 30‑day basis, and beta is low, indicating limited market‑wide sensitivity. However, trading volume has been declining, raising liquidity concerns despite a sizable market cap.
Fundamental outlook: Orion shows exceptional profitability, with ROE well above 40% and a strong operating margin. Revenue growth has accelerated sharply, and the PE multiple is comfortably below the sector average, suggesting relative undervaluation. The dividend yield near 2.6% is backed by a payout ratio under 50% and healthy free cash flow, supporting its sustainability. While a DCF model implies a lower intrinsic value, the combination of growth, cash generation, and defensive sector positioning makes the stock attractive for medium‑ to long‑term investors.
Fundamental outlook: Orion shows exceptional profitability, with ROE well above 40% and a strong operating margin. Revenue growth has accelerated sharply, and the PE multiple is comfortably below the sector average, suggesting relative undervaluation. The dividend yield near 2.6% is backed by a payout ratio under 50% and healthy free cash flow, supporting its sustainability. While a DCF model implies a lower intrinsic value, the combination of growth, cash generation, and defensive sector positioning makes the stock attractive for medium‑ to long‑term investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support with bullish SMA alignment
- Negative MACD histogram and decreasing volume
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high ROE
- PE multiple below industry average
- Sustainable dividend yield
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust product pipeline and market diversification
- Low beta indicating defensive characteristics
- Consistent cash generation supporting dividend and reinvestment
Key Metrics & Analysis
Financial Health
Revenue Growth60.10%
Profit Margin26.48%
P/E Ratio19.2
ROE43.70%
ROA21.70%
Debt/Equity23.78
P/B Ratio7.5
Op. Cash Flow€316.8M
Free Cash Flow€124.2M
Industry P/E26.2
Technical Analysis
TrendBullish
RSI47.9
Support€67.57
Resistance€70.45
MA 20€68.60
MA 50€67.93
MA 200€65.32
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value€31.49
GradeFair
TypeGrowth
Dividend Yield2.64%
Risk Assessment
Beta0.18
Volatility40.35%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.